PRIC295, a nuclear receptor coactivator, identified from PPARα -interacting cofactor complex

PPAR Research

Volumn , Issue , 2010, Pages

  Reddy, Janardan K ^a   Pyper, Sean R ^a   Viswakarma, Navin ^a   Jia, Yuzhi ^a   Zhu, Yi Jun ^a   Fondell, Joseph D ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MED1 PROTEIN; MED24 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA INTERACTING COFACTOR 295; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR BINDING;

EID: 77957967849     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2010/173907     Document Type: Article

References (92)

1. Issemann and S. Green, "Activation of a member ofthe steroid hormone receptor superfamily by peroxisomeproliferators," Nature, vol. 347, no. 6294, pp. 645-650, 1990.
2. C. Dreyer, G. Krey, H. Keller, F. Givel, G. Helftenbein, and W. Wahli, "Control of the peroxisomal β-oxidation pathway by anovel family of nuclear hormone receptors," Cell, vol. 68, no.5, pp. 879-887, 1992.
3. B. Desvergne and W. Wahli, "Peroxisome proliferatoractivatedreceptors: nuclear control of metabolism," EndocrineReviews, vol. 20, no. 5, pp. 649-688, 1999.
4. J. K. Reddy and T. P. Krishnakantha, "Hepatic peroxisomeproliferation: induction by two novel compounds structurallyunrelated to clofibrate," Science, vol. 190, no. 4216, pp. 787-789, 1975.
5. J. K. Reddy, M. S. Rao, and D. E. Moody, "Hepatocellularcarcinomas in acatalasemic mice treated with Nafenopin, ahypolipidemic peroxisome proliferator," Cancer Research, vol.36, no. 4, pp. 1211-1217, 1976.
6. J. K. Reddy, D. L. Azarnoff, and C. E. Hignite, " Hypolipidaemichepatic peroxisome proliferators form a novel class ofchemical carcinogens," Nature, vol. 283, no. 5745, pp. 397-398, 1980.
7. J. K. Reddy, S. K. Goel, and M. R. Nemali, " Transcriptionalregulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liverby peroxisome proliferators," Proceedings of the NationalAcademy of Sciences of the United States of America, vol. 83, no.6, pp. 1747-1751, 1986.
8. N. D. Lalwani, M. K. Reddy, and S. A. Qureshi, "Evaluationof selected hypolipidemic agents for the induction of peroxisomalenzymes and peroxisome proliferation in the rat liver,"Human Toxicology, vol. 2, no. 1, pp. 27-48, 1983.
9. E. K. Maloney and D. J.Waxman, "Trans-activation of PPARaand PPAR? by structurally diverse environmental chemicals,"Toxicology and Applied Pharmacology, vol. 161, no. 2, pp. 209-218, 1999.
10. J. K. Reddy and R. Chu, "Peroxisome proliferator-inducedpleiotropic responses: pursuit of a phenomenon," Annals of theNew York Academy of Sciences, vol. 804, pp. 176-201, 1996.
11. M. S. Rao and J. K. Reddy, "Peroxisome proliferation andhepatocarcinogenesis," Carcinogenesis, vol. 8, no. 5, pp. 631-636, 1987.
12. P. R. Devchand, H. Keller, J. M. Peters, M. Vazquez, F. J.Gonzalez, and W.Wahli, "The PPARa-leukotriene B4 pathwayto inflammation control," Nature, vol. 384, no. 6604, pp. 39-43, 1996.
13. M. Ricote and C. K. Glass, "PPARs andmolecularmechanismsof transrepression," Biochimica et Biophysica Acta, vol. 1771,no. 8, pp. 926-935, 2007.
14. F. Zandbergen and J. Plutzky, "PPARa in atherosclerosis andinflammation," Biochimica et Biophysica Acta, vol. 1771, no. 8,pp. 972-982, 2007.
15. B. Staels, M. Maes, and A. Zambon, "Fibrates and futurePPARa agonists in the treatment of cardiovascular disease,"Nature Clinical Practice Cardiovascular Medicine, vol. 5, no. 9,pp. 542-553, 2008.
16. S. S.-T. Lee, T. Pineau, J. Drago et al., "Targeted disruptionof the a isoform of the peroxisome proliferator-activatedreceptor gene in mice results in abolishment of the pleiotropiceffects of peroxisome proliferators," Molecular and CellularBiology, vol. 15, no. 6, pp. 3012-3022, 1995.
17. J. K. Reddy, "Peroxisome proliferators and peroxisomeproliferator- activated receptor a: biotic and xenobiotic sensing,"American Journal of Pathology, vol. 164, no. 6, pp. 2305-2321, 2004.
18. S. R. Pyper, N. Viswakarma, S. Yu, and J. K. Reddy, "PPARa:energy combustion, hypolipidemia, inflammation and cancer,"Nuclear Receptor Signaling, vol. 8, article no. e002, 2010.
19. J. Direnzo, M. Söderström, R. Kurokawa et al., "Peroxisomeproliferator-activated receptors and retinoic acid receptorsdifferentially control the interactions of retinoid X receptorheterodimers with ligands, coactivators, and corepressors, "Molecular and Cellular Biology, vol. 17, no. 4, pp. 2166-2176,1997.
20. J. D. Tugwood, I. Issemann, R. G. Anderson, K. R. Bundell,W. L. McPheat, and S. Green, "The mouse peroxisomeproliferator activated receptor recognizes a response elementin the 5 flanking sequence of the rat acyl CoA oxidase gene,"EMBO Journal, vol. 11, no. 2, pp. 433-439, 1992
21. S. A. Kliewer, K. Umesono, D. J. Noonan, R. A. Heyman, andR. M. Evans, "Convergence of 9-cis retinoic acid and peroxisomeproliferator signalling pathways through heterodimerformation of their receptors," Nature, vol. 358, no. 6389, pp.771-774, 1992.
22. B. Zhang, S. L. Marcus, F. G. Saijadi et al., "Identificationof a peroxisome proliferator-responsive element upstream ofthe gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase," Proceedings of the NationalAcademy of Sciences of the United States of America, vol. 89, no.16, pp. 7541-7545, 1992.
23. J. D. Chen and R. M. Evans, "A transcriptional co-repressorthat interacts with nuclear hormone receptors," Nature, vol.377, no. 6548, pp. 454-457, 1995.
24. R. Kurokawa, M. Soderstrom, A. Horlein et al., " Polarityspecificactivities of retinoic acid receptors determined by aco-repressor," Nature, vol. 377, no. 6548, pp. 451-454, 1995.
25. P.Dowell, J. E. Ishmael, D. Avram, V. J. Peterson, D. J. Nevrivy,and M. Leid, "Identification of nuclear receptor corepressoras a peroxisome proliferator-activated receptor a interactingprotein," Journal of Biological Chemistry, vol. 274, no. 22, pp.15901-15907, 1999.
26. E. Treuter, T. Albrektsen, L. Johansson, J. Leers, and J.-A.Gustafsson, "A regulatory role for RIP140 in nuclear receptoractivation," Molecular Endocrinology, vol. 12, no. 6, pp. 864-881, 1998.
27. C. K. Glass and M. G. Rosenfeld, "The coregulator exchangein transcriptional functions of nuclear receptors," Genes andDevelopment, vol. 14, no. 2, pp. 121-141, 2000.
28. Y.-J. Kim, S. Björklund, Y. Li, M. H. Sayre, and R. D. Kornberg,"A multiprotein mediator of transcriptional activation andits interaction with the C-terminal repeat domain of RNApolymerase II," Cell, vol. 77, no. 4, pp. 599-608, 1994.
29. S. A. Onate, S. Y. Tsai, M.-J. Tsai, and B. W. O?Malley,"Sequence and characterization of a coactivator for the steroidhormone receptor superfamily," Science, vol. 270, no. 5240, pp.1354-1357, 1995.
30. Y. Zhu, C. Qi, S. Jain, M. S. Rao, and J. K. Reddy, "Isolationand characterization of PBP, a protein that interacts with peroxisomeproliferator- activated receptor," Journal of BiologicalChemistry, vol. 272, no. 41, pp. 25500-25506, 1997.
31. Y. Zhu, C. Qi, W.-Q. Cao, A. V. Yeldandi, M. S. Rao,and J. K. Reddy, "Cloning and characterization of PIMT, aprotein with a methyltransferase domain, which interacts withand enhances nuclear receptor coactivator PRIP function,"Proceedings of the National Academy of Sciences of the UnitedStates of America, vol. 98, no. 18, pp. 10380-10385, 2001.
32. Y. Zhu, C. Qi, C. Calandra, M. S. Rao, and J. K. Reddy,"Cloning and identification of mouse steroid receptorcoactivator-1 (mSRC-1), as a coactivator of peroxisomeproliferator-activated receptor gamma," Gene Expression, vol.6, no. 3, pp. 185-195, 1996.
33. S. Surapureddi, S. Yu, H. Bu et al., "Identification ofa transcriptionally active peroxisome proliferator-activatedreceptor a-interacting cofactor complex in rat liver andcharacterization of PRIC285 as a coactivator," Proceedingsof the National Academy of Sciences of the United States ofAmerica, vol. 99, no. 18, pp. 11836-11841, 2002.
34. S. Surapureddi, N. Viswakarma, S. Yu, D. Guo, M. S. Rao, andJ. K. Reddy, "PRIC320, a transcription coactivator, isolatedfrom peroxisome proliferator-binding protein complex," Biochemicaland Biophysical Research Communications, vol. 343,no. 2, pp. 535-543, 2006.
35. R. P. S. Kwok, J. R. Lundblad, J. C. Chrivia et al., "Nuclearprotein CBP is a coactivator for the transcription factorCREB," Nature, vol. 370, no. 6486, pp. 223-226, 1994
36. Z. Wang, C. Qi, A. Krones et al., "Critical roles of thep160 transcriptional coactivators p/CIP and SRC-1 in energybalance," Cell Metabolism, vol. 3, no. 2, pp. 111-122, 2006.
37. D. Chekravarti, V. J. LaMorte, M. C. Nelson et al., "Role ofCBP/P300 in nuclear receptor signalling," Nature, vol. 383, no.6595, pp. 99-103, 1996.
38. R. H. Goodman and S. Smolik, "CBP/p300 in cell growth, transformation, and development," Genes and Development,vol. 14, no. 13, pp. 1553-1577, 2000.
39. R. D. Kornberg, "The molecular basis of eukaryotic transcription,"Proceedings of the National Academy of Sciences of theUnited States of America, vol. 104, no. 32, pp. 12955-12961,2007.
40. C.-X. Yuan, M. Ito, J. D. Fondell, Z.-Y. Fu, and R. G. Roeder,"The TRAP220 component of a thyroid hormone receptorassociatedprotein (TRAP) coactivator complex interactsdirectly with nuclear receptors in a ligand-dependent fashion,"Proceedings of the National Academy of Sciences of the UnitedStates of America, vol. 95, no. 14, pp. 7939-7944, 1998.
41. C. Rachez, B. D. Lemon, Z. Suldan et al., "Ligand- dependenttranscription activation by nuclear receptors requires theDRIP complex," Nature, vol. 398, no. 6730, pp. 824-828, 1999.
42. S. Malik and R. G. Roeder, "Dynamic regulation of pol IItranscription by the mammalian mediator complex," Trendsin Biochemical Sciences, vol. 30, no. 5, pp. 256-263, 2005.
43. J. K. Reddy, D. Guo, Y. Jia, S. Yu, and M. S. Rao, "Nuclearreceptor transcriptional coactivators in development andmetabolism," Advances in Developmental Biology, vol. 16, pp.389-420, 2006.
44. A. M. Näär, P. A. Beaurang, S. Zhou, S. Abraham, W.Solomon, and R. Tjian, "Composite co-activator ARC mediateschromatin-directed transcriptional activation," Nature,vol. 398, no. 6730, pp. 828-832, 1999.
45. R. D. Kornberg, "Mediator and the mechanism of transcriptionalactivation," Trends in Biochemical Sciences, vol. 30, no.5, pp. 235-239, 2005.
46. Y. Zhu, L. Kan, C. Qi et al., ?Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR," Journal of Biological Chemistry, vol. 275, no. 18, pp. 13510-13516, 2000.
47. S.-K. Lee, S. L. Anzick, J.-E. Choi et al., "A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essentialfor ligand-dependent transactivation by nuclear receptors invivo," Journal of Biological Chemistry, vol. 274, no. 48, pp.34283-34293, 1999.
48. F. Caira, P. Antonson, M. Pelto-Huikko, E. Treuter, and J.-A. Gustafsson, "Cloning and characterization of RAP250, a novelnuclear receptor coactivator," Journal of Biological Chemistry,vol. 275, no. 8, pp. 5308-5317, 2000.
49. M. A. Mahajan and H. H. Samuels, "A new family ofnuclear receptor coregulators that integrate nuclear receptorsignaling through CREB-binding protein," Molecular andCellular Biology, vol. 20, no. 14, pp. 5048-5063, 2000.
50. Y.-J. Zhu, S. E. Crawford, V. Stellmach et al., "CoactivatorPRIP, the peroxisome proliferator-activated receptorinteractingprotein, is a modulator of placental, cardiac,hepatic, and embryonic development," Journal of BiologicalChemistry, vol. 278, no. 3, pp. 1986-1990, 2003.
51. D. Chen, M. Ma, H. Hong et al., "Regulation of transcriptionby a protein methyltransferase," Science, vol. 284, no. 5423, pp.2174-2177, 1999.
52. I. Shur, R. Socher, and D. Benayahu, "In vivo association ofCReMM/CHD9 with promoters in osteogenic cells," Journalof Cellular Physiology, vol. 207, no. 2, pp. 374-378, 2006.
53. P. Puigserver, Z. Wu, C. W. Park, R. Graves, M. Wright, andB. M. Spiegelman, "A cold-inducible coactivator of nuclearreceptors linked to adaptive thermogenesis," Cell, vol. 92, no.6, pp. 829-839, 1998.
54. J. Lin, P. Puigserver, J. Donovan, P. Tarr, and B.M. Spiegelman, "Peroxisome proliferator-activated receptor ? coactivator 1β(PGC-1β), a novel PGC-1-related transcription coactivatorassociated with host cell factor," Journal of Biological Chemistry,vol. 277, no. 3, pp. 1645-1648, 2002.
55. C. Qi, Y. Zhu, and J. K. Reddy, "Peroxisome proliferatoractivatedreceptors, coactivators, and downstream targets,"Cell Biochemistry and Biophysics, vol. 32, pp. 187-204, 2000.
56. J. J. Voegel, M. J. S. Heine, M. Tini, V. Vivat, P. Chambon, andH. Gronemeyer, "The coactivator TIF2 contains three nuclearreceptor-binding motifs andmediates transactivation throughCBP binding-dependent and -independent pathways," EMBOJournal, vol. 17, no. 2, pp. 507-519, 1998.
57. K. Matsumoto, S. Yu, Y. Jia et al., "Critical role for transcriptioncoactivator peroxisome proliferator-activated receptor(PPAR)- binding protein/TRAP220 in liver regeneration andPPARa ligand-induced liver tumor development," Journal ofBiological Chemistry, vol. 282, no. 23, pp. 17053-17060, 2007.
58. S. Yu, K. Matsusue, P. Kashireddy et al., "Adipocyte-specificgene expression and adipogenic steatosis in the mouseliver due to peroxisome proliferator-activated receptor ?1(PPAR?1) overexpression," Journal of Biological Chemistry,vol. 278, no. 1, pp. 498-505, 2003.
59. K. Ge, M. Guermah, C.-X. Yuan et al., "Transcriptioncoactivator TRAP220 is required for PPAR?2-stimulatedadipogenesis," Nature, vol. 417, no. 6888, pp. 563-567, 2002.
60. J. Zhang and J. D. Fondell, "Identification of mouse TRAP100:a transcriptional coregulatory factor for thyroid hormone andvitamin D receptors," Molecular Endocrinology, vol. 13, no. 7,pp. 1130-1140, 1999.
61. N. D. Lalwani, K. Alvares, and M. K. Reddy, "Peroxisomeproliferator- binding protein: identification and partial characterizationof nafenopin-, clofibric acid-, and ciprofibratebindingproteins from rat liver," Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no.15, pp. 5242-5246, 1987.
62. P. Misra, C. Qi, S. Yu et al., "Interaction of PIMT with transcriptional coactivators CBP, p300, and PBP differential role in transcriptional regulation," Journal of Biological Chemistry, vol. 277, no. 22, pp. 20011-20019, 2002.
63. N. Webster, J. R. Jin, S. Green, M. Hollis, and P. Chambon, "The yeast UASG is a transcriptional enhancer in human hela cells in the presence of the GAL4 trans-activator," Cell, vol. 52, no. 2, pp. 169-178, 1988.
64. C. Ji, W. Chang, M. Centrella, and T. L.McCarthy, "Activation domains of CCAAT enhancer binding protein δ: regions required for native activity and prostaglandin E2-dependent transactivation of insulin-like growth factor I gene expression in rat osteoblasts," Molecular Endocrinology, vol. 17, no. 9, pp. 1834-1843, 2003.
65. M. Karas, D. Bachmann, and F. Hillenkamp, "Influence of the wavelength in high-irradiance ultraviolet laser desorption mass spectrometry of organic molecules," Analytical Chemistry, vol. 57, no. 14, pp. 2935-2939, 1985.
66. A. Marchler-Bauer, J. B. Anderson, F. Chitsaz et al., "CDD: specific functional annotation with the Conserved Domain Database," Nucleic Acids Research, vol. 37, no. 1, pp. D205-D210, 2009.
67. M. A. Andrade, C. Petosa, S. I.O'Donoghue, C.W.Müller, and P. Bork, "Comparison of ARM and HEAT protein repeats," Journal of Molecular Biology, vol. 309, no. 1, pp. 1-18, 2001.
68. Y.-H. Goo, Y. Chang Sohn, D.-H. Kim et al., "Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins," Molecular and Cellular Biology, vol. 23, no. 1, pp. 140-149, 2003.
69. S. Lee, D.-H. Kim, Y. H. Goo, Y. C. Lee, S.-K. Lee, and J. W. Lee, "Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation," Molecular Endocrinology, vol. 23, no. 5, pp. 610-619, 2009.
70. W.-J. Lin, J. D. Gary, M. C. Yang, S. Clarke, and H. R. Herschman, "The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase," Journal of Biological Chemistry, vol. 271, no. 25, pp. 15034-15044, 1996.
71. Z. Cao, R. M. Umek, and S. L. McKnight, "Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells," Genes and Development, vol. 5, no. 9, pp. 1538-1552, 1991.
72. H. Xiao, Y. Tao, and R. G. Roeder, "The human homologue of Drosophila TRF-proximal protein is associated with an RNA polymerase II-SRB complex," Journal of Biological Chemistry, vol. 274, no. 7, pp. 3937-3940, 1999.
73. W. Fan, Z. Wang, F. Kyzysztof, C. Prange, and G. Lennon, "A new zinc ribbon gene (ZNRD1) is cloned from the human MHC class I region," Genomics, vol. 63, no. 1, pp. 139-141, 2000.
74. B. W. O'Malley and R. Kumar, "Nuclear receptor coregulators in cancer biology," Cancer Research, vol. 69, no. 21, pp. 8217-8222, 2009.
75. L. C. Myers and R. D. Kornberg, "Mediator of transcriptional regulation," Annual Review of Biochemistry, vol. 69, pp. 729-749, 2000.
76. R. G. Roeder, "Transcriptional regulation and the role of diverse coactivators in animal cells," FEBS Letters, vol. 579, no. 4, pp. 909-915, 2005.
77. M. Belakavadi and J. D. Fondell, "Role of the mediator complex in nuclear hormone receptor signaling," Reviews of Physiology, Biochemistry and Pharmacology, vol. 156, pp. 23-43, 2006.
78. L. Wang, G. Lam, and C. S. Thummel, "Med24 and Mdh2are required for Drosophila larval salivary gland cell death,"Developmental Dynamics, vol. 239, no. 3, pp. 954-964, 2010.
79. Z. Shaikhibrahim, H. Rahaman, P. Wittung-Stafshede, and S.Björklund, "Med8, Med18, and Med20 subunits of the mediatorhead domain are interdependent upon each other forfolding and complex formation," Proceedings of the NationalAcademy of Sciences of the United States of America, vol. 106,no. 49, pp. 20728-20733, 2009.
80. M. T. Bedford and S. Richard, "Arginine methylation: anemerging regulator of protein function," Molecular Cell, vol.18, no. 3, pp. 263-272, 2005.
81. C. Teyssier, H. Ma, R. Emter, A. Kralli, and M. R. Stallcup, "Activation of nuclear receptor coactivator PGC-1a by argininemethylation, " Genes and Development, vol. 19, no. 12, pp.1466-1473, 2005.
82. J. Yu, B. Shin, E.-S. Park et al., "Protein arginine methyltransferase1 regulates herpes simplex virus replication throughICP27 RGG-box methylation," Biochemical and BiophysicalResearch Communications, vol. 391, no. 1, pp. 322-328, 2010.
83. W. Wahli, O. Braissant, and B. Desvergne, "Peroxisomeproliferator activated receptors: transcriptional regulators ofadipogenesis, lipid metabolism and more," Chemistry andBiology, vol. 2, no. 5, pp. 261-266, 1995.
84. C. Zang, H. Liu, J. Bertz et al., "Induction of endoplasmicreticulum stress response by TZD18, a novel dual ligandfor peroxisome proliferator-activated receptor a/?, in humanbreast cancer cells," Molecular Cancer Therapeutics, vol. 8, no.8, pp. 2296-2307, 2009.
85. W. Guo, Y.-P. Zhao, Y.-G. Jiang, R.-W. Wang, L. Hong,and D.-M. Fan, "Upregulation of ZNRD1 enhances cisplatinresistance in human esophageal cancer cells by regulation ofERCC1 and Bcl-2," Tumor Biology, vol. 29, no. 3, pp. 188-194,2008.
86. E. Ballana, J. Senserrich, E. Pauls et al., "ZNRD1 (zinc ribbondomain-containing 1) is a host cellular factor that influencesHIV-1 replication and disease progression," Clinical InfectiousDiseases, vol. 50, no. 7, pp. 1022-1032, 2010.
87. Y. Jia, G. L. Guo, S. Surapureddi et al., "Transcription coactivatorperoxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity,"Proceedings of the National Academy of Sciences of theUnited States of America, vol. 102, no. 35, pp. 12531-12536,2005.
88. C. Qi, Y. Zhu, J. Pan et al., "Mouse steroid receptor coactivator-1 is not essential for peroxisome proliferator-activated receptora-regulated gene expression," Proceedings of the NationalAcademy of Sciences of the United States of America, vol. 96, no.4, pp. 1585-1590, 1999.
89. D. Balciunas, C. Gälman, H. Ronne, and S. Björklund, "TheMed1 subunit of the yeast mediator complex is involved inboth transcriptional activation and repression," Proceedingsof the National Academy of Sciences of the United States ofAmerica, vol. 96, no. 2, pp. 376-381, 1999.
90. Y.Zhu,C.Qi, Y. Jia, J. S. Nye,M. S. Rao, and J.K.Reddy, "Deletionof PBP/PARBP, the gene for nuclear receptor coactivatorperoxisome proliferator-activated receptor-binding protein,results in embryonic lethality," Journal of Biological Chemistry,vol. 275, no. 20, pp. 14779-14782, 2000.
91. M. Ito, C.-X. Yuan, H. J. Okano, R. B. Darnell, and R. G.Roeder, "Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action," Molecular Cell, vol. 5, no. 4, pp.683-693, 2000.
92. S. Malik, M. Guermah, C.-X. Yuan, W. Wu, S. Yamamura,and R. G. Roeder, "Structural and functional organizationof TRAP220, the TRAP/mediator subunit that is targeted bynuclear receptors," Molecular and Cellular Biology, vol. 24, no.18, pp. 8244-8254, 2004.